Cargando…

Muscular myostatin gene expression and plasma concentrations are decreased in critically ill patients

BACKGROUND: The objective was to investigate the role of gene expression and plasma levels of the muscular protein myostatin in intensive care unit-acquired weakness (ICUAW). This was performed to evaluate a potential clinical and/or pathophysiological rationale of therapeutic myostatin inhibition....

Descripción completa

Detalles Bibliográficos
Autores principales:	Grunow, Julius J., Reiher, Katja, Carbon, Niklas M., Engelhardt, Lilian Jo, Mai, Knut, Koch, Susanne, Schefold, Joerg C., Z’Graggen, Werner, Schaller, Stefan J., Fielitz, Jens, Spranger, Joachim, Weber-Carstens, Steffen, Wollersheim, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347123/ https://www.ncbi.nlm.nih.gov/pubmed/35922829 http://dx.doi.org/10.1186/s13054-022-04101-1

Ejemplares similares

Muscular weakness and muscle wasting in the critically ill
por: Schefold, Joerg C., et al.
Publicado: (2020)

Impact of protocol‐based physiotherapy on insulin sensitivity and peripheral glucose metabolism in critically ill patients
por: Carbon, Niklas M., et al.
Publicado: (2022)

Sex-Specific Aspects of Skeletal Muscle Metabolism in the Clinical Context of Intensive Care Unit-Acquired Weakness
por: Engelhardt, Lilian Jo, et al.
Publicado: (2022)

Correction: Engelhardt et al. Sex-Specific Aspects of Skeletal Muscle Metabolism in the Clinical Context of Intensive Care Unit-Acquired Weakness. J. Clin. Med. 2022, 11, 846
por: Engelhardt, Lilian Jo, et al.
Publicado: (2022)

Muscle wasting and function after muscle activation and early protocol‐based physiotherapy: an explorative trial
por: Wollersheim, Tobias, et al.
Publicado: (2019)

Differential contractile response of critically ill patients to neuromuscular electrical stimulation
por: Grunow, Julius J., et al.
Publicado: (2019)

Assessment of magnetic flux density properties of electromagnetic noninvasive phrenic nerve stimulations for environmental safety in an ICU environment
por: Kuhn, K. Friedrich, et al.
Publicado: (2021)

Association between potassium concentrations, variability and supplementation, and in-hospital mortality in ICU patients: a retrospective analysis
por: Engelhardt, Lilian Jo, et al.
Publicado: (2019)

Randomised controlled trial using daily electrical muscle stimulation (EMS) in critically ill patients to prevent intensive care unit (icu) acquired weakness (ICUAW)
por: Goll, M, et al.
Publicado: (2015)

Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial
por: Wollersheim, Tobias, et al.
Publicado: (2016)

SPSB1‐mediated inhibition of TGF‐β receptor‐II impairs myogenesis in inflammation
por: Li, Yi, et al.
Publicado: (2023)

Whole-body vibration to prevent intensive care unit-acquired weakness: safety, feasibility, and metabolic response
por: Wollersheim, Tobias, et al.
Publicado: (2017)

Dysfunction of respiratory muscles in critically ill patients on the intensive care unit
por: Berger, David, et al.
Publicado: (2016)

First non-invasive magnetic phrenic nerve and diaphragm stimulation in anaesthetized patients: a proof-of-concept study
por: Panelli, Alessandro, et al.
Publicado: (2023)

Cornelia : roman
por: Z'Graggen, Yvette
Publicado: (1985)

Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock
por: Schefold, Joerg C., et al.
Publicado: (2010)

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
por: Kemaladewi, Dwi U, et al.
Publicado: (2011)

Identification and Characterization of a Non-muscular Myostatin in the Nile Tilapia
por: Segev-Hadar, Adi, et al.
Publicado: (2020)

Accuracy of a subcutaneous continuous glucose management system in critically ill patients
por: Engelhardt, L, et al.
Publicado: (2015)

Anesthesia modality does not affect clinical outcomes of intra-arterial vasodilator treatment in patients with symptomatic cerebral vasospasms
por: Fischer, Corinne, et al.
Publicado: (2021)

Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
por: Harish, Pradeep, et al.
Publicado: (2019)

Skeletal Muscle 11beta-HSD1 Controls Glucocorticoid-Induced Proteolysis and Expression of E3 Ubiquitin Ligases Atrogin-1 and MuRF-1
por: Biedasek, Katrin, et al.
Publicado: (2011)

Relation of Resting Membrane Polarization and Insulin Resistance in Critically Ill Patients
por: Koch, S, et al.
Publicado: (2015)

The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy
por: Schmidt, Franziska, et al.
Publicado: (2014)

Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications
por: Rodriguez, Belén, et al.
Publicado: (2022)

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020)

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
por: Zhou, Haiyan, et al.
Publicado: (2020)

LOW-INTENSITY EXERCISE ENHANCES MUSCULAR ANDROGEN/ANDROGEN RECEPTOR TO INHIBIT MYOSTATIN PATHWAY
por: Son, Bo-Kyung, et al.
Publicado: (2019)

Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy
por: Nishiyama, Atsushi, et al.
Publicado: (2007)

Evaluation of Electrical Impedance as a Biomarker of Myostatin Inhibition in Wild Type and Muscular Dystrophy Mice
por: Sanchez, Benjamin, et al.
Publicado: (2015)

MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy
por: Marozzo, Roberta, et al.
Publicado: (2020)

Inflammation-Induced Acute Phase Response in Skeletal Muscle and Critical Illness Myopathy
por: Langhans, Claudia, et al.
Publicado: (2014)

Potassium and the Excitability Properties of Normal Human Motor Axons In Vivo
por: Boërio, Delphine, et al.
Publicado: (2014)

Glycemic variability as a risk factor of intensive care unit-acquired weakness
por: Mörgeli, R, et al.
Publicado: (2015)

Development and early diagnosis of critical illness myopathy in COVID‐19 associated acute respiratory distress syndrome
por: Rodriguez, Belén, et al.
Publicado: (2022)

Nimodipine-Induced Blood Pressure Changes Can Predict Delayed Cerebral Ischemia
por: Fischer, Corinne, et al.
Publicado: (2019)

The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle
por: Rybalka, Emma, et al.
Publicado: (2020)

Improvement of muscular atrophy by AAV–SaCas9-mediated myostatin gene editing in aged mice
por: Weng, Shaoting, et al.
Publicado: (2020)

Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine(ratio), and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy
por: van de Velde, Nienke M., et al.
Publicado: (2023)

Is myopathy part of long-Covid?
por: Rodriguez, Belén, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hh3lbn6ccuhs00d8607p8umlta